Combretastatin A4丨CAS 117048-59-6

Combretastatin A4丨CAS 117048-59-6
Product Introduction:
Catalog No.: SS120011
CAS No.: 117048-59-6
Assay: 97% min
Product Name: Combretastatin A4
Molecular Formula: C18H20O5
Molecular Weight: 316.35
Synonym(s): (Z)-2-Methoxy-5-(3,4,5-trimethoxystyryl)phenol
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of combretastatin a4丨cas 117048-59-6 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance White powder
Assay 97% min
Melting point 84-85 °C
Identification The HPLC RT of sample matches with standard
Unspecified impurity (HPLC) 2% max
Petroleum 20 ppm max
Ethyl acetate 20 ppm max
Heavy Metals 20 ppm max
Loss on Drying 1% max

 

 

 

Applications

 

Combretastatin A4 is a potent natural product primarily investigated for its anticancer properties. It functions as a vascular disrupting agent (VDA), targeting and collapsing the blood vessels that supply tumors, thereby inhibiting tumor growth. It is widely studied in preclinical and clinical research for the treatment of various cancers, including solid tumors such as ovarian, thyroid, and lung cancers. In medicinal chemistry, it also serves as a lead compound for the development of analogs and prodrugs with improved solubility and bioavailability. Furthermore, it is used as a biochemical tool to study tubulin dynamics, as it binds to the colchicine site of tubulin and inhibits microtubule assembly.

 

Benefits

 

Combretastatin A4 demonstrates strong antitumor activity by selectively targeting tumor vasculature while sparing most normal blood vessels, reducing damage to healthy tissues. Its mechanism of action offers a different approach from conventional chemotherapy, making it a valuable candidate for combination therapy to enhance treatment outcomes. Structural simplicity and modifiability allow researchers to create derivatives that improve pharmacokinetic properties, stability, and clinical applicability. The compound's effectiveness in disrupting microtubules also makes it useful for fundamental cell biology studies.

 

Conclusion

 

Combretastatin A4 is a highly significant bioactive compound in oncology research, offering a unique mechanism to inhibit tumor growth through vascular disruption. Its versatility as both a therapeutic candidate and a research tool underscores its importance in drug discovery and cancer biology. Continued study and development of its derivatives hold promise for advancing targeted cancer therapies and improving patient outcomes.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us